Page last updated: 2024-08-21

eosine yellowish-(ys) and Candidiasis, Vulvovaginal

eosine yellowish-(ys) has been researched along with Candidiasis, Vulvovaginal in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Feng, X; Hu, K; Shao, J; Shi, G; Wang, C; Wang, T; Wu, D; Zhang, H	1

Other Studies

1 other study(ies) available for eosine yellowish-(ys) and Candidiasis, Vulvovaginal

Article	Year
Longdan Xiegan decoction ameliorates vulvovaginal candidiasis by inhibiting the NLRP3 inflammasome via the Toll-like receptor /MyD88 pathway. Journal of ethnopharmacology, 2024, Jan-10, Volume: 318, Issue:Pt A Topics: Animals; Candida albicans; Candidiasis, Vulvovaginal; Caspases; Cytokines; Eosine Yellowish-(YS); Female; Hematoxylin; Humans; Inflammasomes; Interleukin-18; Mice; Myeloid Differentiation Factor 88; NF-kappa B; NLR Family, Pyrin Domain-Containing 3 Protein; Toll-Like Receptor 2; Toll-Like Receptor 4	2024

Article

Year

Longdan Xiegan decoction ameliorates vulvovaginal candidiasis by inhibiting the NLRP3 inflammasome via the Toll-like receptor /MyD88 pathway.

Journal of ethnopharmacology, 2024, Jan-10, Volume: 318, Issue:Pt A

Topics: Animals; Candida albicans; Candidiasis, Vulvovaginal; Caspases; Cytokines; Eosine Yellowish-(YS); Female; Hematoxylin; Humans; Inflammasomes; Interleukin-18; Mice; Myeloid Differentiation Factor 88; NF-kappa B; NLR Family, Pyrin Domain-Containing 3 Protein; Toll-Like Receptor 2; Toll-Like Receptor 4

2024